Erick Wayne De Vinney is Chief Innovation Officer of Axogen, Inc.. Currently has a direct ownership of 179,974 shares of AXGN, which is worth approximately $2.93 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 2,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 180K
0% 3M change
58.74% 12M change
Total Value Held $2.93 Million

Erick Wayne DeVinney Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
BUY
Grant, award, or other acquisition
-
2,500 Added 1.37%
179,974 Common Stock
Mar 21 2024
SELL
Open market or private sale
$35,159 $7.68 p/Share
4,578 Reduced 2.51%
177,474 Common Stock
Mar 16 2024
BUY
Exercise of conversion of derivative security
-
18,675 Added 9.37%
180,615 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 23.43%
163,377 Common Stock
Oct 13 2023
SELL
Sale (or disposition) back to the issuer
$3,490 $4.04 p/Share
864 Reduced 0.76%
113,377 Common Stock
Jul 18 2023
BUY
Grant, award, or other acquisition
-
1,579 Added 1.36%
114,241 Common Stock
Mar 16 2023
SELL
Payment of exercise price or tax liability
$22,899 $8.27 p/Share
2,769 Reduced 2.4%
112,662 Common Stock
Mar 16 2023
BUY
Exercise of conversion of derivative security
-
8,900 Added 7.27%
113,596 Common Stock
Dec 27 2022
SELL
Payment of exercise price or tax liability
$1,765 $9.44 p/Share
187 Reduced 0.18%
106,531 Common Stock
Dec 27 2022
SELL
Payment of exercise price or tax liability
$101,800 $9.44 p/Share
10,784 Reduced 9.24%
105,968 Common Stock
Dec 27 2022
BUY
Exercise of conversion of derivative security
-
750 Added 0.7%
106,718 Common Stock
Dec 27 2022
BUY
Exercise of conversion of derivative security
$101,800 $5.09 p/Share
20,000 Added 14.63%
116,752 Common Stock
Jul 19 2022
SELL
Sale (or disposition) back to the issuer
$3,402 $8.4 p/Share
405 Reduced 0.42%
96,752 Common Stock
Jul 18 2022
BUY
Grant, award, or other acquisition
-
1,579 Added 1.65%
94,157 Common Stock
Mar 16 2022
SELL
Payment of exercise price or tax liability
$11,931 $7.97 p/Share
1,497 Reduced 1.59%
92,578 Common Stock
Mar 16 2022
BUY
Exercise of conversion of derivative security
-
6,000 Added 6.0%
94,075 Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$3,006 $8.42 p/Share
357 Reduced 0.4%
88,075 Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
-
1,181 Added 1.32%
88,432 Common Stock
Dec 27 2021
SELL
Payment of exercise price or tax liability
$1,821 $9.74 p/Share
187 Reduced 0.21%
87,249 Common Stock
Dec 27 2021
BUY
Exercise of conversion of derivative security
-
750 Added 0.85%
87,436 Common Stock
Dec 20 2021
SELL
Payment of exercise price or tax liability
$1,331 $9.24 p/Share
144 Reduced 0.17%
86,686 Common Stock
Dec 20 2021
BUY
Exercise of conversion of derivative security
-
575 Added 0.66%
86,830 Common Stock
Dec 15 2021
SELL
Payment of exercise price or tax liability
$36,705 $8.8 p/Share
4,171 Reduced 4.61%
86,255 Common Stock
Dec 15 2021
BUY
Exercise of conversion of derivative security
$36,700 $3.67 p/Share
10,000 Added 9.96%
90,426 Common Stock
Jul 20 2021
SELL
Payment of exercise price or tax liability
$7,526 $19.2 p/Share
392 Reduced 0.49%
80,426 Common Stock
EWD

Erick Wayne De Vinney

Chief Innovation Officer
Alachua, FL

Track Institutional and Insider Activities on AXGN

Follow Axogen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXGN shares.

Notify only if

Insider Trading

Get notified when an Axogen, Inc. insider buys or sells AXGN shares.

Notify only if

News

Receive news related to Axogen, Inc.

Track Activities on AXGN